Muhammad Latif

1.5k total citations
77 papers, 1.0k citations indexed

About

Muhammad Latif is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Muhammad Latif has authored 77 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Muhammad Latif's work include Cancer therapeutics and mechanisms (8 papers), Quinazolinone synthesis and applications (7 papers) and Nanoparticles: synthesis and applications (5 papers). Muhammad Latif is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Quinazolinone synthesis and applications (7 papers) and Nanoparticles: synthesis and applications (5 papers). Muhammad Latif collaborates with scholars based in Pakistan, Saudi Arabia and South Korea. Muhammad Latif's co-authors include Muhammad Sohail Zafar, Zaman Ashraf, Zohaib Khurshid, Sulman Basit, Aamer Saeed, Kwangho Lee, Abdul Ghaffar, Qingrong Huang, Muhammad Amber Fareed and Syed Rashid Habib and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Organic Chemistry.

In The Last Decade

Muhammad Latif

69 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Latif Pakistan 18 284 226 120 116 86 77 1.0k
Wenjing Liu China 22 396 1.4× 169 0.7× 93 0.8× 77 0.7× 134 1.6× 63 1.2k
Satoshi Inoue Japan 19 352 1.2× 179 0.8× 138 1.1× 167 1.4× 59 0.7× 43 1.3k
Stephan Reichl Germany 28 424 1.5× 167 0.7× 194 1.6× 346 3.0× 80 0.9× 81 2.3k
Samar Mansour Egypt 30 661 2.3× 215 1.0× 81 0.7× 198 1.7× 100 1.2× 61 2.8k
Richard A Moravec United States 13 659 2.3× 129 0.6× 161 1.3× 205 1.8× 97 1.1× 21 1.5k
Yongtao Li China 23 583 2.1× 109 0.5× 175 1.5× 79 0.7× 42 0.5× 98 1.3k
Kiran Sonaje Taiwan 18 824 2.9× 150 0.7× 104 0.9× 238 2.1× 142 1.7× 21 2.8k
Rudee Surarit Thailand 25 499 1.8× 84 0.4× 114 0.9× 136 1.2× 31 0.4× 102 1.6k
Arindam Mondal United States 20 446 1.6× 102 0.5× 203 1.7× 304 2.6× 121 1.4× 66 1.3k
Yuanyuan Gao China 22 364 1.3× 93 0.4× 62 0.5× 138 1.2× 65 0.8× 57 1.4k

Countries citing papers authored by Muhammad Latif

Since Specialization
Citations

This map shows the geographic impact of Muhammad Latif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Latif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Latif more than expected).

Fields of papers citing papers by Muhammad Latif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Latif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Latif. The network helps show where Muhammad Latif may publish in the future.

Co-authorship network of co-authors of Muhammad Latif

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Latif. A scholar is included among the top collaborators of Muhammad Latif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Latif. Muhammad Latif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbas, Naeem, et al.. (2025). Schiff bases targeting an Sw-480 colorectal cell line: synthesis, characterization, ds-DNA binding and anticancer studies. RSC Advances. 15(3). 1527–1539. 1 indexed citations
3.
Ismail, Amir, Muhammad Riaz, Kashif Razzaq, et al.. (2025). Artificial Ripening of Mangoes Marketed in Pakistan: Impact on Physicochemical Properties and Occurrence of Potentially Toxic Elements. Journal of Food Safety. 45(3).
5.
Latif, Muhammad, et al.. (2024). Identification of Novel and Recurrent Variants in BTD, GBE1, AGL and ASL Genes in Families with Metabolic Disorders in Saudi Arabia. Journal of Clinical Medicine. 13(5). 1193–1193. 1 indexed citations
8.
Bilal, Muhammad, et al.. (2023). Indole-3-acetic acid (IAA) doping on the surface of CuO-NPs reduces the toxic effects of NPs on Lactuca sativa. Journal of Biotechnology. 367. 53–61. 4 indexed citations
9.
Irfan, Hafiz Muhammad, Alamgeer Umme Habiba Hasan, Aman Ullah, et al.. (2022). Noscapine hydrochloride (benzyl-isoquinoline alkaloid) effectively prevents protein denaturation through reduction of IL-6, NF-kB, COX-2, Prostaglandin-E2 in rheumatic rats. Saudi Pharmaceutical Journal. 30(12). 1791–1801. 6 indexed citations
11.
Latif, Muhammad, Sudhanshu Shukla, Perla M. Del Río Estrada, et al.. (2021). Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection. Translational research. 241. 83–95. 14 indexed citations
12.
Huang, Qingrong, et al.. (2020). A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films. Pharmaceutics. 12(2). 131–131. 61 indexed citations
13.
Latif, Muhammad, et al.. (2020). Induction-remission response in pediatric acute lymphoblastic leukemia, Lahore protocol versus UKALL 2011 interim guidelines. Journal of the Pakistan Medical Association. 70(0). 1–1. 3 indexed citations
14.
Latif, Muhammad, et al.. (2019). Comparison of Direct Trocar versus Veress Needle Insertion in Creation of Pneumoperitoneum in Patients Undergoing Laparoscopic Cholecystectomy. 13(2). 126–129. 1 indexed citations
15.
Latif, Muhammad, Zaman Ashraf, Sulman Basit, et al.. (2018). Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments. RSC Advances. 8(30). 16470–16493. 6 indexed citations
16.
Hashmi, Jamil Amjad, et al.. (2018). An 18 bps in-frame deletion mutation in RUNX2 gene is a population polymorphism rather than a pathogenic variant. European Journal of Medical Genetics. 62(2). 124–128. 9 indexed citations
17.
Lee, Hyeon Ji, Muhammad Latif, Imran Ali, et al.. (2014). ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment. Archives of Pharmacal Research. 37(9). 1130–1138. 11 indexed citations
18.
Saeed, Aamer, Najim A. Al‐Masoudi, & Muhammad Latif. (2013). Synthesis and Antiviral Activity of New Substituted Methyl [2‐(arylmethylene‐hydrazino)‐4‐oxo‐thiazolidin‐5‐ylidene]acetates. Archiv der Pharmazie. 346(8). 618–625. 20 indexed citations
19.
Nasir, Amar, et al.. (2013). Molecular detection of Clostridium perfringens type D alpha and epsilon toxin genes from various tissues in lambs.. Pakistan Veterinary Journal. 33(4). 492–495. 4 indexed citations
20.
Sattar, Abdus, et al.. (2005). PRODUCTIVE AND REPRODUCTIVE PERFORMANCE OF HOLSTEIN-FRIESIAN COWS IN PAKISTAN. Pakistan Veterinary Journal. 25(2). 75–81. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026